Erlotinib therapy in non small cell lung cancer patients - survival of patients on reduced erlotinib doses

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

PEŠEK Miloš KREJČÍ Jana SKŘIČKOVÁ Jana ZATLOUKAL Petr KOLEK Vítězslav SALAJKA František KOUBKOVÁ Leona SIXTOVÁ Dimka PETRUŽELKA Luboš ROUBEC Jaromír VYZULA Rostislav PAVLÍK Tomáš

Year of publication 2009
Type Article in Periodical
Magazine / Source Journal of Thoracic Oncology
MU Faculty or unit

Faculty of Medicine

Citation
Field Pneumology
Keywords erlotinib in reduced doses; treatment of NSCLC
Description The question of survival of non small cell lung cancer patients treated with reduced doses of erlotinib is broached in the paper.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.